ASSISTED REPRODUCTIVE TECHNOLOGY TREATMENT OUTCOMES IN TRANSGENDER MALES WITH HISTORY OF GENDER AFFIRMING HORMONE THERAPY

There has been increased access to assisted reproductive technology (ART) treatment for transgender and gender diverse (TGD) patients. Yet, limited research has assessed fertility in patients who undergo gender affirming hormone therapy (GAHT). We evaluated the effect of testosterone (T) therapy in transgender males and ART treatment outcome.